EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Advances in Peptide‐Based Cancer Vaccines: Materials, Targeting, and Delivery Strategies

Shea Garland iD, Jacques Lux iD

WIREs Nanomedicine and Nanobiotechnology · 2026

DOI: 10.1002/wnan.70044 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift WIREs Nanomedicine and Nanobiotechnology, 2026. Verfasst von Shea Garland und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Translational Research in Ultrasound Theranostics (TRUST) Program, University of Texas Southwestern Medical Center, Dallas, …. Hauptthemen laut MEDLINE: Cancer Vaccines, Drug Delivery Systems, Neoplasms, Peptides. Die Arbeit nennt 92 Literaturangaben. Gefördert von: American Brain Tumor Association.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Immunotherapy, particularly immune checkpoint inhibitors (ICIs), has transformed cancer treatment by achieving durable responses in a subset of patients. However, the effectiveness of ICIs is often limited by factors such as low tumor expression of PD‐L1 and low tumor mutational burden, which contribute to immune evasion in “cold” tumors. Cancer vaccination through the delivery of tumor antigens offers a promising strategy to enhance antigen‐specific immune priming and improve the responses to ICIs. Despite this potential, peptide‐based cancer vaccines face several challenges, including immune tolerance, insufficient antigen delivery and presentation, and the immunosuppressive tumor microenvironment. To overcome these barriers, novel platforms are being developed to codeliver antigens with immunostimulatory agents. In this review, we highlight recent advances in peptide‐based cancer vaccine design, including innovative materials, adjuvants, targeting strategies, and controlled release mechanisms. We also discuss their translation and how these approaches may ultimately expand the benefit of immunotherapy to patients with treatment‐refractory cancers. This article is categorized under: Therapeutic Approaches and Drug Discovery > Emerging Technologies Biology‐Inspired Nanomaterials > Peptide‐Based Structures Biology‐Inspired Nanomaterials > Lipid‐Based Structures

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cancer VaccinesDrug Delivery SystemsNeoplasmsPeptidesHumansAnimalsImmunotherapyVaccines, Subunit

Stichwörter der Autor:innen

antigendrug deliveryimmunotherapyneoantigenvaccine

Substanzen

Cancer VaccinesPeptidesVaccines, Subunit

Autor:innen und Institutionen

  • Department of Radiology, Translational Research in Ultrasound Theranostics (TRUST) Program, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
  • Department of Biomedical Engineering, University of Texas Southwestern Medical Center, Dallas, Texas, USA.

ORCID-Profile: Shea Garland, Jacques Lux

Förderung

  • American Brain Tumor Association

Zitieren

APA

Garland, S., & Lux, J. (2026). Advances in Peptide‐Based Cancer Vaccines: Materials, Targeting, and Delivery Strategies. WIREs Nanomedicine and Nanobiotechnology. https://doi.org/10.1002/wnan.70044

Vancouver

Garland S, Lux J. Advances in Peptide‐Based Cancer Vaccines: Materials, Targeting, and Delivery Strategies. WIREs Nanomedicine and Nanobiotechnology. 2026. doi:10.1002/wnan.70044

BibTeX
@article{Garland2026,
  author = {Garland, Shea and Lux, Jacques},
  title = {Advances in Peptide‐Based Cancer Vaccines: Materials, Targeting, and Delivery Strategies},
  journal = {WIREs Nanomedicine and Nanobiotechnology},
  year = {2026},
  doi = {10.1002/wnan.70044}
}
Kostenlos starten →